A Safety And Pharmacokinetic Study With CVX-045 In Patients With Advanced Solid Tumors
NCT00879554
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
40
Enrollment
INDUSTRY
Sponsor class
Conditions
Advanced Solid Tumors
Neoplasms
Carcinoma
Cancer
Malignancy
Interventions
BIOLOGICAL:
CVX-045
Sponsor
Pfizer